Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the research, development, cultivation, manufacture, and distribution of medical cannabis and related products. It also provides training and patient care services. The company is based in Nof Hagalil, Israel.
Tikun Olam-Cannbit Pharmaceuticals Dividend Announcement
• Tikun Olam-Cannbit Pharmaceuticals announced a quarterly dividend of ₪28.23 per ordinary share which will be made payable on . Ex dividend date: 2011-12-28
• Tikun Olam-Cannbit Pharmaceuticals's trailing twelve-month (TTM) dividend yield is -%
Tikun Olam-Cannbit Pharmaceuticals Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2011-12-28 | ₪28.23 | quarterly | |
| 2011-10-09 | ₪17.64 | quarterly | |
| 2011-09-06 | ₪17.64 | quarterly | |
| 2011-03-31 | ₪12.35 | quarterly | |
| 2010-12-07 | ₪38.81 | quarterly | |
| 2010-02-01 | ₪68.28 | quarterly | |
| 2008-11-16 | ₪17.64 | quarterly | |
| 2006-06-08 | ₪81.16 | quarterly | |
| 2005-08-17 | ₪40.58 | quarterly | |
| 2002-09-01 | ₪10.58 | quarterly |
Tikun Olam-Cannbit Pharmaceuticals Dividend per year
Tikun Olam-Cannbit Pharmaceuticals Dividend growth
Tikun Olam-Cannbit Pharmaceuticals Dividend Yield
Tikun Olam-Cannbit Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tikun Olam-Cannbit Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Tikun Olam-Cannbit Pharmaceuticals Financial Ratios
P/E ratio-0.35
PEG ratio-0.50
P/B ratio1.27
ROE-183.20%
Payout ratio0.00%
Current ratio0.60
Quick ratio0.48
Cash Ratio0.16
Tikun Olam-Cannbit Pharmaceuticals Dividend FAQ
Does Tikun Olam-Cannbit Pharmaceuticals stock pay dividends?
Tikun Olam-Cannbit Pharmaceuticals does not currently pay dividends to its shareholders.
Has Tikun Olam-Cannbit Pharmaceuticals ever paid a dividend?
No, Tikun Olam-Cannbit Pharmaceuticals has no a history of paying dividends to its shareholders. Tikun Olam-Cannbit Pharmaceuticals is not known for its dividend payments.
Why doesn't Tikun Olam-Cannbit Pharmaceuticals pay dividends?
There are several potential reasons why Tikun Olam-Cannbit Pharmaceuticals would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tikun Olam-Cannbit Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tikun Olam-Cannbit Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tikun Olam-Cannbit Pharmaceuticals a dividend aristocrat?
Tikun Olam-Cannbit Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tikun Olam-Cannbit Pharmaceuticals a dividend king?
Tikun Olam-Cannbit Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tikun Olam-Cannbit Pharmaceuticals a dividend stock?
No, Tikun Olam-Cannbit Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tikun Olam-Cannbit Pharmaceuticals stocks?
To buy Tikun Olam-Cannbit Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Tikun Olam-Cannbit Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Tikun Olam-Cannbit Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.